In The News,

Case Study: Novel Car T-Cell Reimbursement and Positioning Strategy

The ADVI Health Value, Access, and Pricing team worked with a novel cell therapy manufacturer to evaluate the reimbursement landscape and product positioning for a game-changing CAR T-cell product. Hear more from Alicia Silver, director of value, access, and pricing, as she shares some insights from this successful oncology partnership.

Video Transcript

Melyssa: In 280 characters, or less, describe a project you engaged in this year which yielded results that you’re proud of.

Alicia: One of the projects that we worked on this year that I’m most proud of is when my team was engaging with a client who is a novel cell therapy manufacturer. They haven’t gone into clinical trials yet. They brought us in to evaluate a product as a game-changing CAR T product by looking at the reimbursement landscape, but also thinking about product positioning. In the process, my team got to learn a lot about the whole landscape for novel CAR T that’s next generation including new platforms and new bedside applications – all really exciting work.

Learn More

Stay ahead of the curve as you look toward 2024. Get in touch today to gain expert insights and strategic counsel on the evolving healthcare landscape.